NEW YORK, June 23, 2020 /PRNewswire/ — BrainStorm Cell Therapeutics Inc. (NasdaqCM: BCLI),  a leading developer of adult...

Allows for enrollment of up to 40 subjects in up to 20 centers SAN DIEGO, June...

Acquired assets expected to deliver attractive payback and achieve a production rate of 1,000 barrels of oil...

NEW YORK, June 15, 2020 (GLOBE NEWSWIRE) — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading...

TULSA, OK, June 10, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — RJD Green (OTCPK: RJDG)...

The fully enrolled placebo-controlled Phase 3 trial is evaluating NurOwn® investigational treatment in ALS patients...

Denver, Colorado, May 19, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — CBD Global Sciences Inc....

FRISCO, Texas, April 06, 2020 (GLOBE NEWSWIRE) — Ecoark Holdings, Inc. (“Ecoark”) (OTC: ZEST), announced...

(TSX: ALS; OTCQX: ATUSF) Altius Minerals Corporation (“Altius” or the “Corporation”) announced that it has received...

BIOQUAL announces the release of two research publications in Science Magazine of our non-human primate...